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The prognostic value of white blood cell  
count-to-mean platelet volume ratio  
in patients with acute coronary syndrome
We have read the article entitled “White 
blood cell count to mean platelet volume ratio as 
a novel non-invasive marker predicting long-term 
outcomes in patients with non-ST elevation acute 
coronary syndrome” [1] with great interest. Both 
leukocytes and platelets have been reported to be 
involved in several cardiovascular (CV) diseases 
through inflammatory pathways. The close rela-
tionship between inflammation, aggregation, and 
atherosclerosis progression has become a field of 
intensive research. The study by Dehghani et al. [1] 
evaluated the predictive role of white blood cell 
count/mean platelet volume (WBC/MPV) ratio 
(WMR) in long-term outcomes of acute coronary 
syndrome (ACS) patients. However, we have some 
comments regarding the presented study.
Previous studies revealed an association be-
tween higher rates of major adverse cardiac events 
and poorer outcomes with both higher platelet and 
lower lymphocyte counts [2–4]. The advantage of 
the platelet-to-lymphocyte ratio (PLR) is that it 
reflects both hyperactive aggregation and inflam-
matory pathways, and it may be superior to either 
the individual platelet or the lymphocyte counts 
in the prediction of long-term outcome in CV 
diseases. Azab et al. [5] showed that higher PLR 
values are associated with higher long-term mor-
tality in patients presenting with non-ST segment 
elevation ACS.  Several additional studies have 
appeared recently, that integrate the predictive risk 
of this novel marker, PLR, in ACS settings [6–9]. 
As increased platelet count and decreased lympho-
cyte levels are associated with poor CV outcome, 
it is logical to integrate these 2 parameters into 1. 
White blood cell count and its differential, 
C-reactive protein and the neutrophil-to-lymphocyte 
ratio are some of the inflammatory markers that 
were demonstrated to have predictive and prog-
nostic significance in a wide range of CV diseases 
including ACS [10–12]. On the other hand, MPV 
is another recent hematologic parameter being 
extensively investigated. A number of studies have 
demonstrated that higher MPV values are associ-
ated with poorer long-term outcome in patients 
presented with ACS [13–15]. Therefore, increased 
levels of both WBC and MPV levels were shown 
to be associated with adverse CV outcomes; the 
proposed novel marker, WMR, would most likely 
blunt the predictive power of these parameters, as 
a result of dividing WBC by MPV.
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